Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir and Re-assessment of Treatment Duration in Patients With Chronic Hepatitis C

NCT02113631 is registered in ClinicalTrials.gov with Louis Stokes VA Medical Center as lead sponsor.

NCT NCT02113631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02113631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir and Re-assessment of Treatment Duration in Patients With Chronic Hepatitis C
Lead sponsor
Louis Stokes VA Medical Center
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2011
Completion date
April 30, 2013
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hepatitis c, chronic